Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AWT020 |
Trade Name | |
Synonyms | AWT-020|AWT 020 |
Drug Descriptions |
AWT020 is a bifunctional fusion protein comprising a PDCD1 (PD-1) antibody and variant form of IL-2, which potentially increases antitumor immune activity and decreases tumor growth (J Immunother Cancer 2022;10 (Suppl 2):1104). |
DrugClasses | PD-L1/PD-1 antibody 123 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AWT020 | AWT020 | 0 | 1 |